WHO
REGULATORY UPDATE
Active Pharmaceutical Ingredient (API) Prequalified
Published: 10/14/2026Detected: 10/14/2026
Summary preview
Prequalifies abacavir (sulfate) API manufactured by Viyash Scientific Limited under WHO’s API prequalification program, enabling regulated access for manufacturers of WHO-prequalified finished pharmaceutical products…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
manufacturing
quality
#WHO prequalification
#API master file (APIMF)
#GMP site evaluation
#abacavir sulfate
#HIV/AIDS
Official Source Document Source Verified
Access the original document directly from WHO.
More from WHO
- New Deadline for Submission: Request for Quotations (RFQ) from interested Notified Bodies - WHO Prequalification Assessment for Medical Devices10/14/2026
- PQT/AMD newsletter - Q3 2026, Issue 54 is now available10/14/2026
- PQ Webinar: Launch of WHO Prequalification of Medical Devices10/14/2026
- VCP Updates - October 202610/14/2026
- New EUL listing10/14/2026